121 related articles for article (PubMed ID: 10643334)
1. [Loss-of-function of AML1/PEBP2 alpha B and leukemogenesis].
Osato M; Ito Y; Asou N
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):40-7. PubMed ID: 10643334
[No Abstract] [Full Text] [Related]
2. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
Mitani K; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
[No Abstract] [Full Text] [Related]
3. AML1 and AML1 fusion protein AML1-ETO in myeloid gene regulation and leukemogenesis.
Zhang DE; Burel S; Zhou L; Hetherington CJ; Yuan Y
Blood Cells Mol Dis; 2001; 27(2):368-76. PubMed ID: 11259158
[No Abstract] [Full Text] [Related]
4. [PEBP2/CBF/AML1: master regulators for tissue specific gene expression].
Ito Y
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):1-6. PubMed ID: 10643328
[No Abstract] [Full Text] [Related]
5. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of leukemogenesis induced by AML 1-MTG 8].
Kitabayashi I; Ohki M
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):26-32. PubMed ID: 10643332
[No Abstract] [Full Text] [Related]
7. AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia.
Barton K; Nucifora G
Bioessays; 2000 Mar; 22(3):214-8. PubMed ID: 10684580
[TBL] [Abstract][Full Text] [Related]
8. AML1 gene in human leukemias: dominant negative effects of the chimeric proteins over wild-type AML1.
Zhang DE
Jpn J Cancer Res; 1997 Jun; 88(6):inside front cover. PubMed ID: 9263526
[No Abstract] [Full Text] [Related]
9. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Licht JD
Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
[No Abstract] [Full Text] [Related]
10. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
12. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
13. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
Xu M; Li D; Lu Y; Chen GQ
Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
[TBL] [Abstract][Full Text] [Related]
14. Leukemogenesis by the chromosomal translocations.
Mitani K
Leukemia; 1997 Apr; 11 Suppl 3():294-6. PubMed ID: 9209370
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the AML1 transcription factor in human leukemia.
Downing JR; Higuchi M; Lenny N; Yeoh AE
Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
[TBL] [Abstract][Full Text] [Related]
16. The runt protein and its companion PEBP2: a close link between this transcription factor and AML.
Ito Y
Leukemia; 1997 Apr; 11 Suppl 3():279-80. PubMed ID: 9209364
[No Abstract] [Full Text] [Related]
17. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
19. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
20. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]